Intentar ORO - Gratis
APAC focuses on bridging eye care gaps
BioSpectrum Asia
|BioSpectrum Asia Sep 2025
Roche APAC Vision Health Survey in 2025 reveals a stark disconnect between vision health concerns and preventive action across Asia Pacific (APAC) - while 91 per cent of adults over 40 express concerns about their vision health, only 28 per cent report undergoing annual or more frequent eye exams.
-
Despite significant advancements in eye care, technological breakthroughs, and increasing global awareness, vast inequities persist in access to quality vision services. Thus, there is a clear need to include eye care in public health plans with coordinated, and accountable pathways. Let's take a look at the current challenges and future possibilities for all stakeholders to prioritise and invest in eye healthcare in APAC.
Over 2.2 billion people globally live with some form of vision impairment or blindness, and alarmingly, at least 1 billion of these cases could have been prevented or are still unaddressed. The challenge is not merely about understanding the scope of the problem, but about transforming insights into practical, scalable, and sustainable solutions. Turning data, research, and innovations into meaningful action lies at the heart of efforts to advance vision health globally.
At the macro level, the World Health Organization (WHO) estimates that poor vision leads to over $400 billion in lost productivity annually. The economic and social costs extend further when factoring in caregiving burdens and reduced independence among older adults. Many eye diseases that develop with age are impossible for individuals to detect on their own without proper vision screening, such as a dilated eye exam. As people get older, those who suffer from vision loss face an increasing overall burden from it.
Esta historia es de la edición BioSpectrum Asia Sep 2025 de BioSpectrum Asia.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE BioSpectrum Asia
BioSpectrum Asia
India Health Fund supports D-Nome to bolster molecular TB screening in India
India Health Fund (IHF), a Tata Trusts initiative, is poised to transform tuberculosis (TB) screening at scale by enabling the development of the world's most affordable molecular screening tool for TB.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
BioOra and Octane Biotech sign LoI to expand cell therapy manufacturing using Cocoon Platform
BioOra, a commercialstage cell therapy company advancing CAR-T therapies for cancer patients, & Canadabased Octane Biotech Inc., an Octane Medical Group Company, has announced the signing of a Letter of Intent (LOI) to collaborate on the co-development & deployment of advanced cell therapies using the Cocoon automated cell therapy manufacturing platform.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
NTU and NHG Health partner to advance healthcare education in Singapore
NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
Gene Solutions introduces non-invasive prenatal screening technology triSure in Taiwan
Singapore-based startup Gene Solutions has introduced triSure, a revolutionary non-invasive prenatal screening technology.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
How FemTech Spurt in APAC is Redefining Healthcare
Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.
4 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
China's Colossal Ageing Population and Low Birth Rate Challenge
China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.
2 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"
At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.
7 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area
Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"
More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.
5 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.
1 min
BioSpectrum Asia May 2026
Listen
Translate
Change font size

